UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The clinical progress of mRNA vaccines and immunotherapies

Nature biotechnology, 2022-06, Vol.40 (6), p.840-854

2022

Volltextzugriff (PDF)

Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency

The New England journal of medicine, 2019-09, Vol.381 (10), p.933-944

2019

Volltextzugriff (PDF)

Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Encenicline, a Selective α7 Nicotinic Receptor Partial Agonist, in Single Ascending-dose and Bioavailability Studies

Clinical therapeutics, 2015-02, Vol.37 (2), p.311-324

2015

Volltextzugriff (PDF)

A phase I/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis II

Genetics in medicine, 2016-01, Vol.18 (1), p.73-81

2016

Volltextzugriff (PDF)

A New Class of Diamine-Based Human Histamine H3 Receptor Antagonists: 4-(Aminoalkoxy)benzylamines

Journal of medicinal chemistry, 2003-08, Vol.46 (18), p.3938-3944

2003

Volltextzugriff (PDF)

Levels of glycosaminoglycans in the cerebrospinal fluid of healthy young adults, surrogate-normal children, and Hunter syndrome patients with and without cognitive impairment

Molecular genetics and metabolism reports, 2015-12, Vol.5 (C), p.103-106

2015

Volltextzugriff (PDF)

Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modeling

Bioorganic & medicinal chemistry, 2008-03, Vol.16 (6), p.2968-2973

2008

Volltextzugriff (PDF)

A phase 1/2 study of intrathecal heparan-N-sulfatase in patients with mucopolysaccharidosis IIIA

Molecular genetics and metabolism, 2016-07, Vol.118 (3), p.198-205

2016

Volltextzugriff (PDF)

Pharmacological characterization of JNJ-28583867, a histamine H3 receptor antagonist and serotonin reuptake inhibitor

European journal of pharmacology, 2007-12, Vol.576 (1-3), p.43-54

2007

Volltextzugriff (PDF)

Dual serotonin transporter/histamine H3 ligands : Optimization of the H3 pharmacophore

Bioorganic & medicinal chemistry letters, 2007-02, Vol.17 (3), p.702-706

2007

Volltextzugriff (PDF)

Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms

British journal of pharmacology, 2006-05, Vol.148 (1), p.102-113

2006

Volltextzugriff (PDF)

Phase 1 Single‐ and Multiple‐Ascending‐Dose Randomized Studies of the Safety, Pharmacokinetics, and Pharmacodynamics of AG‐348, a First‐in‐Class Allosteric Activator of Pyruvate Kinase R, in Healthy Volunteers

Clinical pharmacology in drug development, 2019-02, Vol.8 (2), p.246-259

2019

Volltextzugriff (PDF)

Aplysamine-1 and related analogs as histamine H3 receptor antagonists

Bioorganic & medicinal chemistry letters, 2006-02, Vol.16 (4), p.897-900

2006

Volltextzugriff (PDF)

Neurocognitive clinical outcome assessments for inborn errors of metabolism and other rare conditions

Molecular genetics and metabolism, 2016-06, Vol.118 (2), p.65-69

2016

Volltextzugriff (PDF)

Immunogenicity of idursulfase and clinical outcomes in very young patients (16 months to 7.5 years) with mucopolysaccharidosis II (Hunter syndrome)

Orphanet journal of rare diseases, 2015-04, Vol.10 (1), p.50, Article 50

2015

Volltextzugriff (PDF)

Radiosynthesis and biodistribution of a histamine H3 receptor antagonist 4-[3-(4-piperidin-1-yl-but-1-ynyl)-[11C]benzyl]-morpholine: evaluation of a potential PET ligand

Nuclear medicine and biology, 2006-08, Vol.33 (6), p.801-810

2006

Volltextzugriff (PDF)

A novel LC-MS/MS assay for heparan sulfate screening in the cerebrospinal fluid of mucopolysaccharidosis IIIA patients

Bioanalysis, 2016-02, Vol.8 (4), p.285-295

2016

Volltextzugriff (PDF)

Behavioral Characterization of Mice Lacking Histamine H3 Receptors

Molecular pharmacology, 2002-08, Vol.62 (2), p.389

2002

Volltextzugriff (PDF)

Characterization of Soluble Forms of Nonchimeric Type V Adenylyl Cyclases

Proceedings of the National Academy of Sciences - PNAS, 1997-04, Vol.94 (7), p.2915-2920

1997

Volltextzugriff (PDF)

Patient Voice in Rare Disease Drug Development and Endpoints

Therapeutic innovation & regulatory science, 2017-03, Vol.51 (2), p.257-263

2017

Volltextzugriff (PDF)

Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitors

Bioorganic & medicinal chemistry letters, 2007-05, Vol.17 (9), p.2603-2607

2007

Volltextzugriff (PDF)

In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor

European journal of pharmacology, 2008-06, Vol.587 (1), p.141-146

2008

Volltextzugriff (PDF)

4-Phenoxypiperidines: Potent, Conformationally Restricted, Non-Imidazole Histamine H3 Antagonists

Journal of medicinal chemistry, 2005-03, Vol.48 (6), p.2229-2238

2005

Volltextzugriff (PDF)

Novel Benzamide-Based Histamine H3 Receptor Antagonists: The Identification of Two Candidates for Clinical Development

ACS medicinal chemistry letters, 2015-04, Vol.6 (4), p.450-454

2015

Volltextzugriff (PDF)

Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists

European journal of medicinal chemistry, 2009-11, Vol.44 (11), p.4413-4425

2009

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(96)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(41)
Humans
(30)
Animals
(27)
Biological And Medical Sciences
(23)
Pharmacology & Pharmacy
(22)
Medical Sciences
(20)
Pharmacology. Drug Treatments
(19)
Rats
(18)
Histamine
(15)
Physical Sciences
(15)
Chemistry, Medicinal
(14)
Male
(14)
Neuropharmacology
(14)
Chemistry
(12)
Neurotransmitters. Neurotransmission. Receptors
(12)
Serotonin
(12)
Histamine Antagonists - Pharmacology
(11)
Chemistry, Organic
(10)
Female
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The clinical progress of mRNA vaccines and immunotherapies

Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency

Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Encenicline, a Selective α7 Nicotinic Receptor Partial Agonist, in Single Ascending-dose and Bioavailability Studies

A phase I/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis II

A New Class of Diamine-Based Human Histamine H3 Receptor Antagonists: 4-(Aminoalkoxy)benzylamines

Levels of glycosaminoglycans in the cerebrospinal fluid of healthy young adults, surrogate-normal children, and Hunter syndrome patients with and without cognitive impairment

Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modeling

A phase 1/2 study of intrathecal heparan-N-sulfatase in patients with mucopolysaccharidosis IIIA

Pharmacological characterization of JNJ-28583867, a histamine H3 receptor antagonist and serotonin reuptake inhibitor

Dual serotonin transporter/histamine H3 ligands : Optimization of the H3 pharmacophore

Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms

Phase 1 Single‐ and Multiple‐Ascending‐Dose Randomized Studies of the Safety, Pharmacokinetics, and Pharmacodynamics of AG‐348, a First‐in‐Class Allosteric Activator of Pyruvate Kinase R, in Healthy Volunteers

Aplysamine-1 and related analogs as histamine H3 receptor antagonists

Neurocognitive clinical outcome assessments for inborn errors of metabolism and other rare conditions

Immunogenicity of idursulfase and clinical outcomes in very young patients (16 months to 7.5 years) with mucopolysaccharidosis II (Hunter syndrome)

Radiosynthesis and biodistribution of a histamine H3 receptor antagonist 4-[3-(4-piperidin-1-yl-but-1-ynyl)-[11C]benzyl]-morpholine: evaluation of a potential PET ligand

A novel LC-MS/MS assay for heparan sulfate screening in the cerebrospinal fluid of mucopolysaccharidosis IIIA patients

Behavioral Characterization of Mice Lacking Histamine H3 Receptors

Characterization of Soluble Forms of Nonchimeric Type V Adenylyl Cyclases

Patient Voice in Rare Disease Drug Development and Endpoints

Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitors

In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor

4-Phenoxypiperidines: Potent, Conformationally Restricted, Non-Imidazole Histamine H3 Antagonists

Novel Benzamide-Based Histamine H3 Receptor Antagonists: The Identification of Two Candidates for Clinical Development

Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists

Suchergebnisse filtern